CD8A and neoplasm: Furthermore, the chemokines CXCL9 and CXCL10 that are greatly implicated in the recruitment of CD8+ T cells to tumor were also upregulated after the treatment with anti-PD-1 antibody, and were further increased in response to the combined treatment (figure 6I).